• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析红树林生物活性代谢产物作为严重急性呼吸综合征冠状病毒2主蛋白酶和受体结合域蛋白的潜在抑制剂:分子动力学和药物代谢及毒性分析

Unraveling bioactive metabolites of mangroves as putative inhibitors of SARS-CoV-2 Mpro and RBD proteins: molecular dynamics and ADMET analysis.

作者信息

Ramasubburayan Ramasamy, Amperayani Karteek Rao, Varadhi Govinda, Dhanraj Ganapathy, Athista Manoharan, Mahapatra Sonalismita, Prakash Santhiyagu

机构信息

Department of Prosthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India.

Department of Organic Chemistry, Gayatri Vidya Parishad College for Degree and PG Courses (Autonomous), Andhra Pradesh, India.

出版信息

J Biomol Struct Dyn. 2024;42(24):13401-13410. doi: 10.1080/07391102.2023.2275185. Epub 2023 Oct 28.

DOI:10.1080/07391102.2023.2275185
PMID:37897196
Abstract

COVID-19 is a deadly pandemic caused by Corona virus leading to millions of deaths worldwide. Till today no medicine was available to cure this disease. This study selected 262 potential bioactive natural products derived from mangroves to inhibit the main protease (Mpro) and receptor-binding domain (RBD) protein of the COVID-19 virus. All the ligands were subjected to Adsorption Digestion Metabolism Excretion and Toxicity (ADMET) predictions and docking studies using AutodockVina. Among all the ligands, NP_143 (Shearinine A) and NP_242 (Amentoflavone), having the highest docking score of 10.2 and 10.1 Kj/mole, respectively, were picked for 100 ns of Molecular Dynamics using GROMACS. The trajectories generated were used to estimate Root mean square deviation (RMSD), Root mean square fluctuations (RMSF), Radius of Gyrations (RG), Solvent accessible surface area (SASA), and Hydrogen bonds. From the data generated, both the ligands have good binding ability at the active site of Mpro protein and do not deviate much. They have strong interactions with the amino acids during the 100 ns of simulations and can thus be considered potential drug candidates.Communicated by Ramaswamy H. Sarma.

摘要

新冠病毒肺炎(COVID-19)是一种由冠状病毒引起的致命大流行病,已导致全球数百万人死亡。直到如今,仍没有可治愈这种疾病的药物。本研究挑选了262种源自红树林的潜在生物活性天然产物,用于抑制新冠病毒的主要蛋白酶(Mpro)和受体结合域(RBD)蛋白。所有配体都通过AutodockVina进行了吸附、消化、代谢、排泄和毒性(ADMET)预测及对接研究。在所有配体中,对接分数最高,分别为10.2和10.1千焦/摩尔的NP_143(蛇纹宁A)和NP_242(穗花杉双黄酮),被挑选出来使用GROMACS进行100纳秒的分子动力学研究。生成的轨迹用于估计均方根偏差(RMSD)、均方根波动(RMSF)、回转半径(RG)、溶剂可及表面积(SASA)和氢键。从生成的数据来看,这两种配体在Mpro蛋白的活性位点都具有良好的结合能力,且偏差不大。在100纳秒的模拟过程中,它们与氨基酸有强烈的相互作用,因此可被视为潜在的药物候选物。由拉马斯瓦米·H·萨尔马传达。

相似文献

1
Unraveling bioactive metabolites of mangroves as putative inhibitors of SARS-CoV-2 Mpro and RBD proteins: molecular dynamics and ADMET analysis.解析红树林生物活性代谢产物作为严重急性呼吸综合征冠状病毒2主蛋白酶和受体结合域蛋白的潜在抑制剂:分子动力学和药物代谢及毒性分析
J Biomol Struct Dyn. 2024;42(24):13401-13410. doi: 10.1080/07391102.2023.2275185. Epub 2023 Oct 28.
2
Analysis of bioactive compounds of as potential inhibitors of SARS-CoV-2 main protease: a pharmacokinetics, molecular docking and molecular dynamics simulation studies.作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶潜在抑制剂的生物活性化合物分析:药代动力学、分子对接和分子动力学模拟研究
J Biomol Struct Dyn. 2025 Feb;43(3):1147-1158. doi: 10.1080/07391102.2023.2291172. Epub 2023 Dec 8.
3
Identification of promising SARS-CoV-2 main protease inhibitor through molecular docking, dynamics simulation, and ADMET analysis.通过分子对接、动力学模拟和ADMET分析鉴定有前景的新型冠状病毒主要蛋白酶抑制剂。
Sci Rep. 2025 Jan 22;15(1):2830. doi: 10.1038/s41598-025-86016-9.
4
Identification of terpenoids as potential inhibitors of SARS-CoV-2 (main protease) and spike (RBD) via computer-aided drug design.通过计算机辅助药物设计鉴定萜类化合物作为 SARS-CoV-2(主要蛋白酶)和刺突(RBD)的潜在抑制剂。
J Biomol Struct Dyn. 2024 Sep;42(15):8145-8158. doi: 10.1080/07391102.2023.2245051. Epub 2023 Aug 7.
5
Molecular Insights into Structural Dynamics and Binding Interactions of Selected Inhibitors Targeting SARS-CoV-2 Main Protease.针对新型冠状病毒2型主要蛋白酶的选定抑制剂的结构动力学和结合相互作用的分子见解
Int J Mol Sci. 2024 Dec 16;25(24):13482. doi: 10.3390/ijms252413482.
6
Insight into crystal structures and identification of potential styrylthieno[2,3-]pyridine-2-carboxamidederivatives against COVID-19 Mpro through structure-guided modeling and simulation approach.通过结构导向建模和模拟方法深入了解晶体结构并鉴定针对 COVID-19 Mpro 的潜在苯乙烯噻吩并[2,3-]吡啶-2-甲酰胺衍生物。
J Biomol Struct Dyn. 2024 May;42(8):4325-4343. doi: 10.1080/07391102.2023.2220799. Epub 2023 Jun 15.
7
Evaluation of phytoconstituents of against K417N and N501Y mutant spike glycoprotein and main protease of SARS-CoV-2- an in silico study.抗 SARS-CoV-2 的 K417N 和 N501Y 突变刺突糖蛋白和主要蛋白酶的植物成分评价 - 一项计算机研究。
J Biomol Struct Dyn. 2023 Jun;41(9):4106-4123. doi: 10.1080/07391102.2022.2062787. Epub 2022 Apr 25.
8
Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19.基于结构的新型地衣化合物筛选对 SARS 冠状病毒主蛋白酶(Mpro)作为 COVID-19 的潜在抑制剂。
Mol Divers. 2021 Aug;25(3):1665-1677. doi: 10.1007/s11030-020-10118-x. Epub 2020 Jun 29.
9
In silico screening of potential inhibitors from Cordyceps species against SARS-CoV-2 main protease.从虫草属物种中筛选针对 SARS-CoV-2 主蛋白酶的潜在抑制剂的计算机筛选。
J Biomol Struct Dyn. 2024 Jun;42(9):4395-4411. doi: 10.1080/07391102.2023.2225110. Epub 2023 Jun 16.
10
Searching possible SARS-CoV-2 main protease inhibitors in constituents from herbal medicines using studies.利用虚拟筛选方法从草药成分中寻找可能的 SARS-CoV-2 主蛋白酶抑制剂。
J Biomol Struct Dyn. 2024 May;42(8):4234-4248. doi: 10.1080/07391102.2023.2220040. Epub 2023 Jun 22.